-
KPV 5mg x 10 Vials
KPV 5mg x 10 Vials. KPV is the tripeptide Lys-Pro-Val, a short sequence associated with the C-terminal region of alpha-melanocyte-stimulating hormone. Its three-residue identity distinguishes it from the full-length parent peptide and from cyclic melanocortin analogues. It can be characterised as a defined small peptide. Pack: 10 vials. 5 mg per vial; 50 mg nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$56.72 -
CJC-1295 Without DAC 10mg x 10 Vials
CJC-1295 Without DAC 10mg x 10 Vials. CJC-1295 is used in catalogue naming for growth-hormone-releasing-hormone-related research peptides. The full designation is important because materials sold with and without a drug-affinity-complex modification are not the same molecular specification. An abbreviated CJC label should be resolved before selecting a structure or formula. Pack: 10 vials. 10 mg per vial; 100 mg nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$170.17 -
DSIP 5mg x 10 Vials
DSIP 5mg x 10 Vials. DSIP stands for delta sleep-inducing peptide, a name used for a defined nonapeptide in experimental literature. The name describes a research identity rather than establishing a particular outcome in an assay. Its nine-residue chain can be examined through sequence-sensitive analytical techniques. Pack: 10 vials. 5 mg per vial; 50 mg nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$56.72 -
TB-500 5mg x 10 Vials
TB-500 5mg x 10 Vials. TB-500 is a catalogue designation used in peptide research. Its relationship to thymosin beta-4 terminology requires particular care: the name alone is not a universally sufficient sequence specification. Before selecting a molecular reference, establish whether the supplied material is a defined fragment, a modified peptide or a full-length thymosin-related preparation. Pack: 10 vials. 5 mg per vial; 50 mg nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$99.27 -
DSIP 15mg x 10 Vials
DSIP 15mg x 10 Vials. DSIP stands for delta sleep-inducing peptide, a name used for a defined nonapeptide in experimental literature. The name describes a research identity rather than establishing a particular outcome in an assay. Its nine-residue chain can be examined through sequence-sensitive analytical techniques. Pack: 10 vials. 15 mg per vial; 150 mg nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$56.72 -
Selank 10mg x 10 Vials
Selank 10mg x 10 Vials. Selank is a synthetic heptapeptide associated with tuftsin-derived peptide research. Its seven-residue identity distinguishes it from Semax, even though the two names often appear together in catalogue blends. Sequence confirmation and formulation composition are separate parts of sample characterisation. Pack: 10 vials. 10 mg per vial; 100 mg nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$56.72 -
BPC-157 10mg + TB-500 10mg x 10 Vials
BPC-157 10mg + TB-500 10mg x 10 Vials. BPC-157 is a synthetic pentadecapeptide: its peptide chain contains fifteen amino-acid residues. Its defined sequence makes it suitable for sequence-based identification and comparison with a qualified reference material. BPC-157 is discussed in experimental peptide literature; the identity of the molecule and the composition of a supplied research sample remain separate questions. TB-500 is a catalogue designation used in peptide research. Its relationship to thymosin beta-4 terminology requires particular care: the name alone is not a universally sufficient sequence specification. Before selecting a molecular reference, establish whether the supplied material is a defined fragment, a modified peptide or a full-length thymosin-related preparation. Pack: 10 vials. 10mg BPC-157 plus 10mg TB-500 per vial (20mg combined); 100mg plus 100mg across 10 vials (200mg combined). Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$241.07 -
Semax 11mg x 10 Vials
Semax 11mg x 10 Vials. Semax is a synthetic heptapeptide related to an adrenocorticotropic-hormone fragment with a Pro-Gly-Pro extension. Its defined sequence distinguishes it from the separately named Selank peptide. The complete name is preferable to the ambiguous abbreviation Sem when selecting a chemical reference. Pack: 10 vials. 11 mg per vial; 110 mg nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$70.90 -
GHRP-2 Acetate 5mg x 10 Vials
GHRP-2 Acetate 5mg x 10 Vials. GHRP-2 is a synthetic growth-hormone-releasing peptide studied in secretagogue receptor systems. Its small peptide structure contains non-standard residue features that are important to reference identity. The number in its name distinguishes it from GHRP-6 and should remain visible in analytical records. Pack: 10 vials. 5 mg per vial; 50 mg nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$42.54 -
GHRP-6 Acetate 5mg x 10 Vials
GHRP-6 Acetate 5mg x 10 Vials. GHRP-6 is a synthetic hexapeptide described in growth-hormone-secretagogue research. Its six-residue structure and stereochemical composition provide a defined basis for analytical characterisation. It should be identified as its own compound rather than treated as a generic synonym for all growth-hormone-releasing peptides. Pack: 10 vials. 5 mg per vial; 50 mg nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$42.54 -
HGH Fragment 176-191 2mg x 10 Vials
HGH Fragment 176-191 2mg x 10 Vials. HGH Fragment 176–191 is a sequence-range designation associated with the C-terminal region of human growth hormone. A fragment contains only a portion of the parent protein, so its chemical identity must be established independently from a full-length HGH preparation. The fragment name alone does not resolve every terminal modification or salt form. Pack: 10 vials. 2 mg per vial; 20 mg nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$70.90 -
HGH 191AA 6 IU x 10 Vials
HGH 191AA 6 IU x 10 Vials. Human growth hormone, also called somatropin in a defined reference context, is a protein whose principal human reference form contains 191 amino-acid residues. Its folded structure is distinct from short growth-hormone fragments and from peptides that act in growth-hormone-related receptor systems. Full-length identity therefore requires more than a broad HGH catalogue label. Pack: 10 vials. 6 IU per vial; 60 IU nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$42.54 -
Dermorphin 5mg x 10 Vials
Dermorphin 5mg x 10 Vials. Dermorphin is a seven-residue peptide associated with amphibian peptide research. Its reference sequence includes a D-alanine residue and an amidated C-terminus. These structural features distinguish it from a peptide containing only the corresponding L-amino acids or an unmodified terminal carboxyl group. Pack: 10 vials. 5 mg per vial; 50 mg nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$70.90 -
HGH 191AA 10 IU x 10 Vials
HGH 191AA 10 IU x 10 Vials. Human growth hormone, also called somatropin in a defined reference context, is a protein whose principal human reference form contains 191 amino-acid residues. Its folded structure is distinct from short growth-hormone fragments and from peptides that act in growth-hormone-related receptor systems. Full-length identity therefore requires more than a broad HGH catalogue label. Pack: 10 vials. 10 IU per vial; 100 IU nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$85.08 -
HGH 191AA 12 IU x 10 Vials
HGH 191AA 12 IU x 10 Vials. Human growth hormone, also called somatropin in a defined reference context, is a protein whose principal human reference form contains 191 amino-acid residues. Its folded structure is distinct from short growth-hormone fragments and from peptides that act in growth-hormone-related receptor systems. Full-length identity therefore requires more than a broad HGH catalogue label. Pack: 10 vials. 12 IU per vial; 120 IU nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$89.34 -
HGH 191AA 15 IU x 10 Vials
HGH 191AA 15 IU x 10 Vials. Human growth hormone, also called somatropin in a defined reference context, is a protein whose principal human reference form contains 191 amino-acid residues. Its folded structure is distinct from short growth-hormone fragments and from peptides that act in growth-hormone-related receptor systems. Full-length identity therefore requires more than a broad HGH catalogue label. Pack: 10 vials. 15 IU per vial; 150 IU nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$120.54 -
Melanotan-1 10mg x 10 Vials
Melanotan-1 10mg x 10 Vials. Melanotan-1, also referenced as Afamelanotide, is a thirteen-residue synthetic analogue of alpha-melanocyte-stimulating hormone. Its structure contains norleucine and a D-phenylalanine residue, together with defined terminal modifications. These details belong to the molecular identity used in laboratory reference comparisons. Pack: 10 vials. 10 mg per vial; 100 mg nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$70.90 -
Gonadorelin Acetate 2mg x 10 Vials
Gonadorelin Acetate 2mg x 10 Vials. Gonadorelin is a decapeptide reference corresponding to gonadotropin-releasing hormone. Its structure includes a modified N-terminal residue and an amidated C-terminus. This catalogue entry specifies the acetate presentation, so the parent-peptide chemistry must remain separate from the counterion and supplied formulation. Pack: 10 vials. 2 mg per vial; 20 mg nominal total across 10 vials. Intended exclusively for controlled in vitro laboratory research; not for human or veterinary use.
$42.54
